Apart from this, PRSs have also been associated with longitudinal cognitive decline [14], as well as specific biomarkers of AD, such as cerebrospinal fluid (CSF) amyloid-beta (Aβ) and Tau, and markers from neuroimaging studies [15,16]. Here, MAPT is linked to Alzheimer disease.